To 1st announcement PDF - Asahi Kasei Bioprocess

PLANOVA WORKSHOP
HAINAN Is., CHINA, 2015
TM
August 20, 2014
Dear valued customer,
Asahi Kasei Medical Co., Ltd. is pleased to announce that
the PlanovaTM Workshop Hainan Is., China will take place
on the following dates and venue.
PlanovaTM Workshop Hainan Is., China
Sanya Marriott Resort & Spa in Hainan Island, China
15 th January, 2015
In China, the Plasma derivatives and biopharmaceutical industry are growing strongly.
And safety issue of those products has become one of the biggest concerns in the
industry. In such circumstances, the need for virus removal filters is becoming greater
and greater.
PlanovaTM filters were launched in 1989 as the first filters developed specifically for
removing viruses from biotherapeutics such as biopharmaceuticals and plasma derivatives. Planova filters have two decades of proven safety and reliability in the international biotherapeutic industry, including China.
In this workshop, more than 10 presentations including examples of the use of Planova
filters will be given. Therefore, this workshop is an excellent chance for attendees to
exchange information with industry experts and become acquainted with Planova filters
and related technical services. The provisional program is provided on the attached
pages.
You will receive further information such as programs, registration details, and accommodation in the 2nd announcement expected to be issued in October, 2014. We are
looking forward to welcome you in Sanya in January.
Yours Sincerely,
Hiroto Kato
General Manager
Asahi Kasei Medical Co., Ltd.
Bioprocess Division
Provisional Schedule
Wednesday, January 14, 2015
17:00- Registration and Welcome Cocktail
19:00- Welcome dinner
Thursday, January 15, 2015
8:50 - 9:00
9:00 - 12:00
12:00 - 13:00
13:00 - 17:00
17:00
19:00 -
Opening Remarks
Sessions
Lunch
Sessions
Closing Remarks
Dinner
Friday, January 16, 2015
Breakfast, followed by check-out
( ★=Titles are tentative and subjected to change)
▼
Provisional Speakers and Presentations
▼
Sami Chtourou, Ph.D., Senior Vice President, Innovations and Scientific Affairs, LFB Biotechnologies, France
State of the art of the IvIG manufacturing
▼
Eckhard Flechsig, Ph.D., Director Pathogen Safety, Biotest AG, Germany
State of the art of the Coagulation factor and Mab Manufacturing ★
▼
Rui Fu, Scientist, National Institutes for Food and Drug Control, China
Viral clearance of Bio Products in China
▼
Albrecht Groener, Ph.D., Head Pathogen Safety, CSL Behring, Germany
State of the art in approaches to ensure the pathogens safety of
Plasma derived products in industry perspective ★
▼
Jifeng Hou, Head of Division of Blood Products, National Institutes for Food and Drug Control, China
Blood Products Safety and Regulation in China
▼
Joseph V. Hughes, Ph.D., Chief Scientist for Virology, Vice President of Service Development, Wuxi Apptec, USA
Validation of Virus Filtration steps ★
▼
T homas Kreil, Ph.D., Associate Professor of Virology, Senior Director Global Pathogen
Safety, Baxter BioScience, Austria
Pathogen Safety of Biological Medicinal Products
▼
Hong Liang, Project Manager, Chengdu Rongsheng Pharmaceuticals Co., Ltd., China
IvIG manufacturing with 35N and evaluation of BioEX for IvIG ★
▼
Zhanjie Liu, Ph.D., Deputy Manager, Shanghai Representative Office of Bioprocess Division,
Asahi Kasei Medical Co., Ltd., Japan
Planova Filters -Virus Removal from Bio-therapeutic Products-
▼
Shan Ma, Head of Research and Development Division, Joint Ventrure Shandong Taibang
Biological Products Co., Ltd., China
BioEX application on IvIG product ★
Tomoyuki Miyabayashi, General Manager, Technical Marketing Department, Bioprocess
Division, Asahi Kasei Medical Co., Ltd., Japan
Asahi Development concept ★
For more information, please contact: Asahi Kasei Medical Co., Ltd. Bioprocess Division
Mr. Kazuhiro Inoue +81-080-1117-6123 Inoue.kcy@om.asahi-kasei.co.jp